Edwards Lifesciences Cash and Equivalents Trend

EW -- USA Stock  

USD 149.81  0.61  0.41%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Cash and Equivalents of Edwards Lifesciences Corporation with missing and latest data points interpolated. A component of Total Assets representing the amount of currency on hand as well as demand deposits with banks or financial institutions.
View

1.5 B

          10 Years Trend
Increasing
Slightly volatile
 Cash and Equivalents 
      Timeline 

Regression Statistics

Arithmetic Mean  552,625,000
Geometric Mean  403,862,121
Coefficient Of Variation  74.82
Mean Deviation  328,212,500
Median  420,400,000
Standard Deviation  413,446,681
Range  1,452,300,000
R Value  0.91
R Squared  0.82
Significance  0.00004881
Slope  103,911,538

Edwards Lifesciences Cash and Equivalents Over Time

2016-12-31  930,100,000 
2017-12-31  930,100,000 
2018-12-31  1,500,000,000 

Other Fundumenentals

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Edwards Lifesciences Upcoming Company Events

Upcoming Quarterly ReportApril 25, 2017
Next Earnings ReportJuly 25, 2017
Additionally see analysis of Edwards Lifesciences Correlation with competitors. Please also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.